Archives for August 22, 2004

← 2004

Acrux aims to make €18m from IPO

Australian drug delivery company Acrux is hoping to raise A$30 million (€18m) in a float on the Australian Stock Exchange to support the development of its novel transdermal technology that does not require the use of adhesive patches or gels.

Chromos gets another ACE partner

Canada's Chromos Molecular Systems has entered into a collaborative agreement with Centocor, a wholly-owned subsidiary of Johnson & Johnson, to develop cell lines for the manufacture of biological drugs.

Sanofi-Aventis merger completes

French pharmaceutical group Sanofi-Synthelabo on Friday formally announced the birth of Sanofi-Aventis, the world's third-largest pharmaceutical company, ranking number one in Europe.

UK firms plan assault on anti-smoking market

BioProgress, a company specialising in the manufacture of films for use in drug formulations, has teamed up with encapsulation company Micap to develop a new type of treatment for those wanting to stop smoking.

Grace expands chromatography business

WR Grace subsidiary The Separations Group has acquired Alltech International in a move that raises its standing in the manufacture and supply of chromatography products even further.